Tissue Mimicking Phantons are artificial materials designed to replicate the acoustic and mechanical properties of human tissues, providing a standardized and controlled medium for testing and calibrating medical imaging devices, particularly ultrasound systems. These phantoms simulate the ultrasonic response of human tissues, aiding in the evaluation and optimization of ultrasound imaging techniques and equipment. Typically composed of polymers, gels, or other materials with acoustic properties similar to those of human tissues, tissue-mimicking phantoms enable researchers and healthcare professionals to assess the performance of ultrasound machines, evaluate image quality, and ensure consistency in measurements. The development of phantoms that accurately mimic specific tissue types, such as liver, muscle, or blood vessels, allows for more realistic and targeted testing. Tissue-mimicking phantoms are crucial for quality assurance in medical imaging, contributing to the standardization and reliability of diagnostic ultrasound procedures. They are also employed in training and education, providing a hands-on tool for healthcare professionals to enhance their skills in ultrasound imaging. Continuous advancements in phantom design and fabrication techniques contribute to the ongoing improvement and standardization of medical imaging technologies.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy